GreenspanF.S.: The thyroid gland.In: Basic and Clinical Endocrinology, GreenspanF.S., BaxtedJ.D. (Eds.), pp. 160–226, Appleton & Lange, East Norwalk, 1994.
2.
HundahllS.A., FlemingI.D., FremgenA.M., MenckH.R.: A national data base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995.Cancer, 83: 2638–2648, 1998.
3.
HazardJ.B., HawkW.A., CrileGJr.: Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity.J Clin Endocrinol Metab, 19: 152–161, 1959.
4.
WellsS.A.Jr., FranzC.: Medullary carcinoma of the thyroid gland.World J Surg, 24: 952–956, 2000.
VerdyM., WeberA.M., RoyC.C., MorinC.L., CadotteM., Bro-chouP.: Hirschsprung's disease in a family with multiple endocrine neoplasia tyoe 2.J Pediatr Gastroenterol Nutr, 1: 603–607, 1982.
10.
MulliganL.M., KwokJ.B., HealeyC.S., ElsonM.J., EngC., GardnerE., LoveD.R., MoleS.E., MooreJ.K., PapiL.: Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.Nature, 363: 458–460, 1993.
11.
WohllkN., CoteG.J., EvansD.B., GoopfertH., OrdonezN.G., GagelR.F.: Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.Endocrinol Metab Clin North Am, 25: 1–25, 1996
12.
NiccoliP., Wion-BarbotN., CaronP., HenryJ-F, De MiccoC., SaintAndre J-P, BigorgneJ-C, ModiglianiE., Conte-DevolxB.: Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients.J Clin Endocrinol Metab.82: 338–341, 1997.
DottoriniM.E., AssiA., SironiM., SangalliG., SpeaficoG., ColomboL.: Multivariate analysis of patients with medullary thyroid carcinoma.Cancer, 77: 1556–1565, 1996.
15.
FuchshuberP.R., LoreeT.R., HicksW.L.Jr., CheneyR.T., SheddD.P.: Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations.Ann Surg Oncol, 5: 81–86, 1998.
16.
KallinowskiF., BuhrH.J., MeybierH., EberhardtM., HerfarthC.: Medullary carcinoma of the thyroid. Therapeutic strategy derived from fifteen years of experience.Surgery, 114: 491–496, 1993.
17.
FlemingJ.B., LeeJ.E., BouvetM., SchultzP.N., ShermanS.I., SellinR.V., FriendK.E., FurgessM.A., CoteG.J., EvansD.B.: Surgical strategy for the treatment of medullary thyroid carcinoma.Ann Surg, 230: 697–707, 1999.
18.
MoleyJ.F., DeBenedettiM.K.: Patterns of nodal metastases in palpable medullary thyroid carcinoma.Ann Surg, 229: 880–888, 1999.
BrierleyJ., TsangR., SompsonW.J.Jr., GospodarowiczM., Sut-cliffeS., PanzarellaT.: Medullary thyroid cancer: analysis of survival and prognostic factors and role of radiation therapy in local control.Thyroid, 6: 305–310, 1996.
21.
BergholmU., BergstromR., EkbomA.: Long-term follow-up of patients with medullary carcinoma of the thyroid.Cancer, 79: 132–138, 1997.
